TY - JOUR T1 - Therapeutic and Clinical Outcomes of Robot-assisted Partial Nephrectomy <em>Versus</em> Cryoablation for T1 Renal Cell Carcinoma JF - In Vivo JO - In Vivo SP - 1573 LP - 1579 DO - 10.21873/invivo.12413 VL - 35 IS - 3 AU - TOSHIHIRO UEMURA AU - TAIGO KATO AU - AKIRA NAGAHARA AU - ATSUNARI KAWASHIMA AU - KOJI HATANO AU - TAKESHI UJIKE AU - YUSUKE ONO AU - HIROKI HIGASHIHARA AU - KAZUTOSHI FUJITA AU - SHINICHIRO FUKUHARA AU - HIROSHI KIUCHI AU - RYOICHI IMAMURA AU - NORIYUKI TOMIYAMA AU - NORIO NONOMURA AU - MOTOHIDE UEMURA Y1 - 2021/05/01 UR - http://iv.iiarjournals.org/content/35/3/1573.abstract N2 - Background: In cT1 renal cell carcinoma (RCC), very few studies have compared oncological outcomes and renal function preservation rates in nephron-sparing robot-assisted partial nephrectomy (RAPN) and percutaneous cryoablation (PCA). Patients and Methods: We retrospectively analysed 126 patients with cT1 RCC treated with RAPN (n=78) and computed tomography-guided PCA (n=48) between March 2016 and November 2019. Clinical data and outcomes were compared for the two groups. Results: There were no significant differences in the 3-year overall survival and relapse-free survival rates in the two groups (p=0.17 and p=0.093, respectively). The median percentage of estimated glomerular filtration rate preservation at 6 months after surgery was 91.8% and 91.4% in the RAPN and PCA groups, respectively (p=0.9). Conclusion: In patients with cT1a RCC, oncological outcomes and renal function appear similar following RAPN and PCA. ER -